Cite
HARVARD Citation
Stubbs, M. et al. (2019). Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura. British journal of haematology. pp. 912-917. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stubbs, M. et al. (2019). Comparison of Rituximab originator (MabThera) to biosimilar (Truxima) in patients with immune‐mediated thrombotic thrombocytopenic purpura. British journal of haematology. pp. 912-917. [Online].